Initial Statement of Beneficial Ownership (3)
March 04 2021 - 5:47PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Sawicki Mark W |
2. Date of Event Requiring Statement (MM/DD/YYYY)
2/25/2021
|
3. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [CYRX]
|
(Last)
(First)
(Middle)
C/O CRYOPORT, INC., 112 WESTWOOD PLACE, SUITE 350 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Chief Scientific Officer / |
(Street)
BRENTWOOD, TN 37027
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 19000 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Option to purchase common stock | (1) | 8/20/2025 | Common Stock | 11342 | $3.07 | D | |
Option to purchase common stock | (2) | 5/6/2026 | Common Stock | 7231 | $1.87 | D | |
Option to purchase common stock | (3) | 3/28/2028 | Common Stock | 68000 | $8.65 | D | |
Option to purchase common stock | (4) | 4/1/2029 | Common Stock | 90000 | $12.79 | D | |
Option to purchase common stock | (5) | 3/30/2030 | Common Stock | 100000 | $16.93 | D | |
Option to purchase common stock | (6) | 5/18/2027 | Common Stock | 11831 | $3.21 | D | |
Option to purchase common stock | (7) | 5/7/2025 | Common Stock | 77625 | $7.80 | D | |
Explanation of Responses: |
(1) | 1/48th of the 156,400 options originally granted vested on the 19th of each month for forty-eight months beginning September 19, 2015. |
(2) | 1/48th of the 70,000 options originally granted vested on the 6th of each month for forty-eight months beginning June 6, 2016. |
(3) | 1/48th of the 68,000 options originally granted vested on the 28th of each month for forty-eight months beginning April 28, 2018. |
(4) | 1/48th of the 90,000 options originally granted vested on the 1st of each month for forty-eight months beginning May 1, 2019. |
(5) | 1/48th of the 100,000 options originally granted vested on the 30th of each month for forty-eight months beginning April 30, 2020. |
(6) | 1/48th of the 78,000 options originally granted vested on the 18th of each month for forty-eight months beginning June 18, 2017. |
(7) | 1/48th of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Sawicki Mark W C/O CRYOPORT, INC. 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD, TN 37027 |
|
| Chief Scientific Officer |
|
Signatures
|
/s/ Mark W. Sawicki | | 3/4/2021 |
**Signature of Reporting Person | Date |
CryoPort (NASDAQ:CYRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
CryoPort (NASDAQ:CYRX)
Historical Stock Chart
From Sep 2023 to Sep 2024